Maoyi Li

Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery

Zhuang Liu, Wenjun Zhu, Z. Dong, 2022, Nature Communications.

Oral delivery of anti-PD-L1 antibody for cancer immunotherapy against orthotopic colorectal tumors

Zhuang Liu, Qian Chen, Jingjing Shen, 2023, Nano Today.

X‐ray‐Induced Release of Nitric Oxide from Hafnium‐Based Nanoradiosensitizers for Enhanced Radio‐Immunotherapy

Zhuang Liu, Junjie Zhu, Guangbao Yang, 2023, Advanced materials.

Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery.

Linfu Chen, Maoyi Li, Jiafei Zhu, 2024, Biomaterials.

Programmable Bacteria‐Based Biohybrids as Living Biotherapeutics for Enhanced Cancer Sonodynamic‐Immunotherapy

Linfu Chen, Feng Pan, Zhaoxin Ji, 2024, Advanced Functional Materials.